[LCID Study Number: 2014-002]
A Multicenter, Global, Observational Study to Collect Information on Safety and to Document the Drug Utilization of Tecfidera™ (dimethyl fumarate) when Used in Routine Medical Practice in the Treatment of Multiple Sclerosis (ESTEEM)
This study is being done to gain a better understanding of the benefits and risks of long term treatment with Tecfidera (dimethyl fumarate) in patients with Multiple Sclerosis (MS). The main purpose of this observational study is to collect information on any side effects that may occur in patients taking Tecfidera.
Primary Contact Email: [email protected]
Primary Contact Phone: 781-744-1930